123 related articles for article (PubMed ID: 27023610)
1. NORE1A Regulates MDM2 Via β-TrCP.
Schmidt ML; Calvisi DF; Clark GJ
Cancers (Basel); 2016 Mar; 8(4):. PubMed ID: 27023610
[TBL] [Abstract][Full Text] [Related]
2. Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.
Schmidt ML; Donninger H; Clark GJ
J Biol Chem; 2014 Nov; 289(45):31102-10. PubMed ID: 25217643
[TBL] [Abstract][Full Text] [Related]
3. Ras Regulates Rb via NORE1A.
Barnoud T; Donninger H; Clark GJ
J Biol Chem; 2016 Feb; 291(6):3114-23. PubMed ID: 26677227
[TBL] [Abstract][Full Text] [Related]
4. NORE1A is a double barreled Ras senescence effector that activates p53 and Rb.
Donninger H; Barnoud T; Clark GJ
Cell Cycle; 2016 Sep; 15(17):2263-4. PubMed ID: 26919075
[TBL] [Abstract][Full Text] [Related]
5. NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
Calvisi DF; Donninger H; Vos MD; Birrer MJ; Gordon L; Leaner V; Clark GJ
Cancer Res; 2009 Jun; 69(11):4629-37. PubMed ID: 19435914
[TBL] [Abstract][Full Text] [Related]
6. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
Donninger H; Calvisi DF; Barnoud T; Clark J; Schmidt ML; Vos MD; Clark GJ
J Cell Biol; 2015 Mar; 208(6):777-89. PubMed ID: 25778922
[TBL] [Abstract][Full Text] [Related]
7. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
Barnoud T; Schmidt ML; Donninger H; Clark GJ
Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and NORE1A Form a Her2/Ras Regulated Tumor Suppressor Complex Modulating Senescence.
Nelson N; Jigo R; Clark GJ
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627161
[TBL] [Abstract][Full Text] [Related]
9. SCF
Ci Y; Li X; Chen M; Zhong J; North BJ; Inuzuka H; He X; Li Y; Guo J; Dai X
Protein Cell; 2018 Oct; 9(10):879-889. PubMed ID: 29497989
[TBL] [Abstract][Full Text] [Related]
10. Distinct control of PERIOD2 degradation and circadian rhythms by the oncoprotein and ubiquitin ligase MDM2.
Liu J; Zou X; Gotoh T; Brown AM; Jiang L; Wisdom EL; Kim JK; Finkielstein CV
Sci Signal; 2018 Nov; 11(556):. PubMed ID: 30425162
[TBL] [Abstract][Full Text] [Related]
11. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
[TBL] [Abstract][Full Text] [Related]
12. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
13. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.
Geli J; Kogner P; Lanner F; Natalishvili N; Juhlin C; Kiss N; Clark GJ; Ekström TJ; Farnebo F; Larsson C
Int J Cancer; 2008 Jul; 123(2):389-394. PubMed ID: 18452173
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase.
Inuzuka H; Tseng A; Gao D; Zhai B; Zhang Q; Shaik S; Wan L; Ang XL; Mock C; Yin H; Stommel JM; Gygi S; Lahav G; Asara J; Xiao ZX; Kaelin WG; Harper JW; Wei W
Cancer Cell; 2010 Aug; 18(2):147-59. PubMed ID: 20708156
[TBL] [Abstract][Full Text] [Related]
15. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers.
Hesson L; Dallol A; Minna JD; Maher ER; Latif F
Oncogene; 2003 Feb; 22(6):947-54. PubMed ID: 12584574
[TBL] [Abstract][Full Text] [Related]
16. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
17. Ras signaling through RASSF proteins.
Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
[TBL] [Abstract][Full Text] [Related]
18. Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma.
Singh A; Erijman A; Noronha A; Kumar H; Peleg Y; Yarden Y; Shifman JM
J Biol Chem; 2021 Dec; 297(6):101353. PubMed ID: 34717958
[TBL] [Abstract][Full Text] [Related]
19. Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.
Stieglitz B; Bee C; Schwarz D; Yildiz O; Moshnikova A; Khokhlatchev A; Herrmann C
EMBO J; 2008 Jul; 27(14):1995-2005. PubMed ID: 18596699
[TBL] [Abstract][Full Text] [Related]
20. The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.
Foukakis T; Au AY; Wallin G; Geli J; Forsberg L; Clifton-Bligh R; Robinson BG; Lui WO; Zedenius J; Larsson C
J Clin Endocrinol Metab; 2006 Mar; 91(3):1143-9. PubMed ID: 16352687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
